Bluefield benefits from the skilled guidance of established leaders whose diverse expertise in discovery research, clinical science and drug development helps move us toward a cure.
Scientific Advisory Board (SAB)
Spryos Artavanis-Tsakonas, Ph.D.
Professor Emeritus of Cell Biology
Harvard Medical School
Dione Kobayashi, Ph.D.
Operating Partner - Translational Innovation Fund
Mass General Brigham
Ian Massey, Ph.D.
Chief Executive Officer
Bruce Miller, M.D.
A.W. and Mary Margaret Clausen Distinguished Professor in Neurology &
Director, Memory and Aging Center
University of California, San Francisco
Steven B. Miller, M.D.
Executive Vice President and Chief Clinical Officer
William C. Mobley, M.D., Ph.D.
Distinguished Professor and Chair, Department of Neurosciences
Executive Director of UCSD's Down Syndrome Center for Research and Treatment
University of California, San Diego